Comparative Pharmacology
Head-to-head clinical analysis: CYANOKIT versus PROTOPAM CHLORIDE.
Peer-Reviewed Evidence
Head-to-head clinical analysis: CYANOKIT versus PROTOPAM CHLORIDE.
CYANOKIT vs PROTOPAM CHLORIDE
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Hydroxocobalamin, a form of vitamin B12, acts as a scavenger of cyanide ions by binding with them to form cyanocobalamin, which is then excreted in urine. It has a higher affinity for cyanide than cytochrome c oxidase, thereby restoring mitochondrial function.
Reactivates acetylcholinesterase inhibited by organophosphate poisoning by binding to the organophosphate moiety, forming a complex that undergoes hydrolysis to regenerate active enzyme. Also has a direct neutralization effect on certain organophosphates.
5 g intravenous infusion over 15 minutes for adults and pediatric patients weighing >=40 kg. A second dose of 5 g may be administered if needed based on clinical response.
1-2 g IV over 15-30 minutes, may repeat after 1 hour if muscle weakness persists, then every 3-8 hours as needed for 24-48 hours.
None Documented
None Documented
The terminal elimination half-life of hydroxocobalamin is approximately 24-28 hours in healthy adults; in cyanide poisoning, the half-life may be prolonged due to reversible binding to cyanide.
Terminal elimination half-life is approximately 1.7 hours in adults. In renal impairment, half-life may be prolonged up to 6 hours, requiring dose adjustment.
Primarily renal elimination as hydroxocobalamin and cyanocobalamin; >90% of an intravenous dose is excreted in urine within 72 hours, with the remainder eliminated in feces via biliary excretion.
Renal excretion is the primary route, with 80-90% of a dose eliminated unchanged in urine within 30 minutes; the remainder is metabolized and excreted fecally.
Category C
Category C
Antidote
Antidote